Hickey, Benjamin, Watson, Ultan, Cleves, Andrew, Alikhan, Raza, Pugh, Neil ORCID: https://orcid.org/0000-0002-6721-2265, Nokes, Leonard ORCID: https://orcid.org/0000-0002-9504-8028 and Perera, Anthony 2018. Does thromboprophylaxis reduce symptomatic venous thromboembolism in patients with below knee cast treatment for foot and ankle trauma? A systematic review and meta-analysis. Foot and Ankle Surgery 24 (1) , pp. 19-27. 10.1016/j.fas.2016.06.005 |
Preview |
PDF
- Accepted Post-Print Version
Download (2MB) | Preview |
Abstract
Background Our aim was to determine the evidence for thromboprophylaxis for prevention of symptomatic venous thromboembolism (VTE) in adults with foot or ankle trauma treated with below knee cast or splint. Our secondary aim was to report major bleeding events. Methods MEDLINE and EMBASE databases were searched for randomized controlled trials from inception to 1st June 2015. Results Seven studies were included. All focused on low molecular weight heparin (LMWH). None found a statistically significant symptomatic DVT reduction individually. At meta-analysis LMWH was protective against symptomatic DVT (OR 0.29, 95% CI 0.09–0.95). Symptomatic pulmonary embolism affected 3/692 (0.43%). None were fatal. 86 patients required LMWH thromboprophylaxis to prevent one symptomatic DVT event. The overall incidence of major bleeding was 1 in 886 (0.11%). Conclusions Low molecular weight heparin reduces the incidence of symptomatic VTE in adult patients with foot or ankle trauma treated with below knee cast or splint.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Engineering |
Publisher: | Elsevier |
ISSN: | 1268-7731 |
Date of First Compliant Deposit: | 14 December 2017 |
Date of Acceptance: | 29 June 2016 |
Last Modified: | 27 Nov 2024 17:00 |
URI: | https://orca.cardiff.ac.uk/id/eprint/107588 |
Citation Data
Cited 11 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
Edit Item |